Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
These include: Patients currently taking another GLP-1 medication cannot take semaglutide at the same time, though they may be able to switch under provider supervision
Safety depends on medical eligibility, clinician oversight, and individual response
Do we add GLP1's for all with personal or family history of substance abuse and/or obesity, metabolic syndrome and/or T2DM
OEM/ODM Capability: Confirm the supplier supports private label ( OEM/ODM ) if branding is required
13b, and Supplementary Data 2)
Sources NEJM (2025): Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
